首页> 美国卫生研究院文献>Nanomaterials >Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor Targeting
【2h】

Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor Targeting

机译:用于多受体靶向的聚乙二醇化三种配体二氧化硅纳米粒子的设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The synthesis of silica nanoparticles (SiNPs) decorated on their surface with a range of various elements (e.g., ligands, drugs, fluorophores, vectors, etc.) in a controlled ratio remains a big challenge. We have previously developed an efficient strategy to obtain in one-step, well-defined multifunctional fluorescent SiNPs displaying fluorophores and two peptides ligands as targeting elements, allowing selective detection of cancer cells. In this paper, we demonstrate that additional level of controlled multifunctionality can be achieved, getting even closer to the original concept of “magic bullet”, using solely sol–gel chemistry to achieve conjugation of PEG chains for stealth, along with three different ligands. In addition, we have answered the recurrent question of the surface ungrafting by investigating the stability of different siloxane linkages with the ERETIC Method (Electronic Reference to Access In Vivo Concentrations) by 19F NMR quantification. We also compared the efficiency of the hybrid silylated fluorophore covalent linkage in the core of the SiNP to conventional methods. Finally, the tumor-cell-targeting efficiency of these multi-ligand NPs on human endothelial cells (HUVEC or HDMEC) and mixed spheroids of human melanoma cells and HUVEC displaying different types of receptors were evaluated in vitro.
机译:在其表面上装饰的二氧化硅纳米颗粒(SINP)的合成,其各种元素(例如,配体,药物,荧光团,荧光团,载体等)仍然是一个很大的挑战。我们之前已经开发了一种有效的策略,以在一步,定义明确的多功能荧光SINPS中获得,显示荧光团和两种肽配体作为靶向元素,允许选择性检测癌细胞。在本文中,我们证明可以实现额外的受控多功能度水平,甚至更接近“魔法子弹”的原始概念,使用Sol-Gel化学来实现PEG链的缀合,以与三种不同的配体一起进行隐形。此外,通过通过研究不同硅氧烷键的稳定性(电子参考以体内浓度的进入),通过19F NMR定量来回答表面未经调节问题。我们还将杂交叶片荧光团共价连杆的效率与SINP的核心进行了比较至常规方法。最后,在体外评估这些多配体NPS对人内皮细胞(HUVEC或HDMEC)和人黑素瘤细胞和HUVEC的混合球体的肿瘤细胞靶向效率和显示不同类型受体的HUVEC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号